[1] Webster AC, Nagler EV, Morton RL, Masson P: Chronic Kidney Disease[J]. Lancet, 2017, 389(10075):1238-1252.
[2] Shroff R, Long DA, Shanahan C. Mechanistic insights into vascular calcification in CKD[J]. J Am Soc Nephrol. 2013;24(2):179-189.
[3] Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, Baum MG, Schiavi S, Hu MC, Moe OW, Kuro-o M: Regulation of fibroblast growth factor-23 signaling by klotho[J]. J Biol Chem 2006, 281:6120-6123.
[4] Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, Yamashita T: Klotho converts canonical FGF receptor into a specific receptor for FGF23[J]. Nature 2006, 444:770-774.
[5] Hu MC, Shi M, Zhang J, Pastor J, Nakatani T, Lanske B, Razzaque MS, Rosenblatt KP, Baum MG, Kuro-o M, Moe OW: Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule[J]. FASEB J 2010, 24:3438-3450.
[6] Wang Y, Sun Z: Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage[J]. Hypertension 2009, 54: 810-817.
[7] Kurosu H, Kuro-o M. The Klotho gene family as a regulator of endocrine fibroblast growth factors[J]. Mol Cell Endocrinol 299:72-78. Molecular & Cellular Endocrinology, 2008, 299(1):72-78.
[8] Sopjani M , Rinnerthaler M , Kruja J , et al. Intracellular Signaling of the Aging Suppressor Protein Klotho[J]. Current Molecular Medicine, 2015, 15(1):27-37.
[9] Kuro-o M. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism.[J]. Current Opinion in Nephrology & Hypertension, 2006, 15(4):437.
[10] Lindberg K, Amin R, Moe OW, et al. The kidney is the principal organ mediating klotho effects[J]. J Am Soc Nephrol. 2014; 25:2169–2175.
[11] Feger M, Mia S, Pakladok T, et al. Down-regulation of renal klotho expression by Shiga toxin 2[J]. Kidney Blood Press Res. 2014; 39:441–449.
[12] Alexander RT, Woudenberg-Vrenken TE, Buurman J, Dijkman H, van der Eerden BC, van Leeuwen JP, Bindels RJ, Hoenderop JG: Klotho prevents renal calcium loss[J]. J Am Soc Nephrol 2009, 20: 2371-2379.
[13] Vervloet M, Cozzolino M. Vascular calcification in chronic kidney disease: different bricks in the wall[J]? Kidney Int. 2017;91(4):808-817.
[14] Lu X, Hu MC. Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease[J]. Kidney Dis (Basel). 2017;3(1):15-23.
[15] Kuro-o M. Klotho in chronic kidney disease--what's new[J]? Nephrol Dial Transplant. 2009;24(6):1705-1708.
[16] 吴明,林评兰,叶朝阳.慢性肾脏病血管钙化的研究进展[J].中国血液净化,2018,17(06):361-365.
[17] Durham AL, Speer MY, Scatena M, Giachelli CM, Shanahan CM. Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness[J]. Cardiovasc Res. 2018;114(4):590-600.
[18] Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing[J]. Nature. 1997;390(6655):45-51.
[19] 常晋瑞,孙娜,南瑛,于玮,齐永芬.Klotho的研究进展[J].生理科学进展,2015,46(04):245-249.
[20] Ogawa Y, Kurosu H, Yamamoto M, Nandi A, Rosenblatt KP, Goetz R, Eliseenkova AV, Mohammadi M, Kuro-o M. β-Klotho is required for metabolic activity of fibroblast growth factor 21[J]. Proc Natl Acad. 2007;1,104(18):7432-7.
[21] Adams AC, Cheng CC, Coskun T, Kharitonenkov A. FGF21 requires β-klotho to act in vivo. PLoS One. 2012;7(11):e49977.
[22]史雨晨,柳景华.血管钙化大鼠模型肾脏β-Klotho及成纤维细胞生长因子受体1表达研究[J].中国循环杂志,2017,32(05):507-510.
[23]戴厚永,杨斌.Klotho与肾损伤及修复的研究进展[J].生理学报,2018,70(06):639-643.
[24] Yamada S, Giachelli CM. Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho[J]. Bone. 2017;100:87-93.
[25] Hu MC, Shi M, Zhang J, et al. Klotho deficiency causes vascular calcification in chronic kidney disease[J]. J Am Soc Nephrol. 2011;22(1):124-136.
[26] Razzaque MS. The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis[J]. Nat Rev Endocrinol. 2009;5(11):611-619.
[27] Lu X, Hu MC. Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease[J]. Kidney Dis (Basel). 2017;3(1):15-23.
[28]马春园,郝丽荣.FGF23-Klotho轴在慢性肾脏病骨矿物质代谢紊乱中的作用[J].医学综述,2015,21(07):1169-1172.
[29] Chen T, Mao H, Chen C, et al. The Role and Mechanism of α-Klotho in the Calcification of Rat Aortic Vascular Smooth Muscle Cells[J]. Biomed Res Int. 2015;2015:194362.
[30] Lim K, Lu TS, Molostvov G, et al. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23[J]. Circulation. 2012;125(18):2243-2255.
[31] Hum JM, O'Bryan LM, Tatiparthi AK, et al. Chronic Hyperphosphatemia and Vascular Calcification Are Reduced by Stable Delivery of Soluble Klotho[J]. J Am Soc Nephrol. 2017;28(4):1162-1174.
[32] Hu MC. Klotho connects intermedin1-53 to suppression of vascular calcification in chronic kidney disease[J]. Kidney Int. 2016;89(3):534-537.
[33] Zhao Y, Zhao MM, Cai Y, et al. Mammalian target of rapamycin signaling inhibition ameliorates vascular calcification via Klotho upregulation[J]. Kidney Int. 2015;88(4):711-721.
[34] Doi S, Zou Y, Togao O, Pastor JV, John GB, Wang L, Shiizaki K, Gotschall R, Schiavi S, Yorioka N, Takahashi M, Boothman DA, Kuro-o M: Klotho inhibits transforming growth factor- beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice[J]. J Biol Chem. 2011; 286: 8655–8665.
[35] Satoh M , Nagasu H , Morita Y , et al. Klotho protects against mouse renal fibrosis by inhibiting Wnt signaling[J]. Am J of Physiol, 2012; 303(12):F1641-F1651.
[36] Hu MC , Shi M , Zhang J , et al.Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective[J]. Kidney Int. 2010; 78:1240–1251.
[37] Drew D, Kritchevsky S, Ix J, Shlipak M, Gutie?rrez OM, Newman A, Hoofnagle A, Fried L, Semba RD, Sarnak M. Association between soluble Klotho and change in kidney function: the health aging and body composition study[J]. J Am Soc Nephro. 2017; l28:1859–1866.
[38] Azuma M , Koyama D , Kikuchi J , et al. Promoter methylation confers kidney-specific expression of the Klotho gene[J]. Faseb J. 2012; 26(10):4264-74.
[39] Liu S, Tang W, Zhou J, et al. Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol. 2006; 17(5):1305–1315.
[40] Lau WL,Leaf EM,Hu MC,et al.Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet[J].Kidney Int,2012,82(12):1261-1270.
[41] Durham AL, Speer MY, Scatena M, Giachelli CM, Shanahan CM. Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness[J]. Cardiovasc Res. 2018, 114(4):590–600.
[42] Yamamoto M, Clark JD, Pastor JV, et al. Regulation of oxidative stress by the anti-aging hormone klotho[J]. J Biol Chem. 2005; 280(45):38029–38034.
